All Work

Paul Ausick

Gas Prices Drop by Double Digits in Most States

Retail gas prices dropped by double digits in most of the United States over the course of the past week, and the national average price for a gallon of gas has reached its lowest…

Paul Ausick · 6 years ago

4.4 Million Jobs Hit by Bar, Restaurant Closures

Five states and New York City have ordered bars and restaurants closed in an effort to slow down the spread of the coronavirus. More than 4.4 million jobs could be temporarily lost.

Paul Ausick · 6 years ago

Oil Stocks Plunge on Oversupply, Crumbling Demand

Oil prices are plummeting again Monday following estimates that up to 10 million barrels of crude will be cut from daily demand as the global economy tries to deal with the coronavirus epidemic and…

Paul Ausick · 6 years ago

How Micron Stock Will Ride Out the Coronavirus

As more businesses and educational institutions turn to online connections during the COVID-19 outbreak, there are companies that stand to benefit in the short term. Among these is Micron Technology.

Paul Ausick · 6 years ago

Sagging Consumer Sentiment Nips Friday Rally in the Bud

Morning Consult's consumer sentiment index took its biggest one-day dive in more than two years Friday, while the University of Michigan survey of consumer sentiment also dropped as the COVID-19 spreads across the United…

Paul Ausick · 6 years ago

How Corporate Welfare May Help Northrop Grumman Stock

Northrop Grumman investors are concerned that the federal government will slow spending on some defense programs to pay the expected high costs to combat the coronavirus outbreak in the United States.

Paul Ausick · 6 years ago

Americans Own Fewer Cars, Drive Fewer Miles

The number of cars per person in the U.S. dropped in 2018 and continues below its peak of a dozen years ago. Miles driven per person are even lower. Is the American love affair…

Paul Ausick · 6 years ago

Are Limited Financing Options Punishing Bio-Path Stock?

Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments…

Paul Ausick · 6 years ago